Clinical trials: Tight control in early RA pays off in the long run

Nature Reviews Rheumatology

Volumn 6, Issue 11, 2010, Pages 623-624

  Scott, David L ^a   Kowalczyk, Anna ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; JOINT INJURY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78049500292     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.174     Document Type: Short Survey

References (10)

1. Rantalaiho, V. et al. Early combination diseasemodifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Res. Ther. 12, R122 (2010).
2. Mottonen, T. et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 353, 1568-1573 (1999).
3. Scott, D. L., Smith, C. & Kingsley, G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin. Exp. Rheumatol. 21 (5 Suppl. 31), S20-S27 (2003).
4. Deighton, C. et al. Management of rheumatoid arthritis: summary of NICE guidance. BMJ 338, b702 (2009).
5. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964-975 (2010).
6. van Tuyl, L. H. et al. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis. Ann. Rheum. Dis. 69, 807-812 (2010).
7. Goekoop-Ruiterman, Y. P. et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann. Intern. Med. 146, 406-415 (2007).
8. Ma, M. H., Kingsley, G. H. & Scott, D. L. A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology 49, 91-98 (2010).
9. Finckh, A. et al. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann. Intern. Med. 151, 612-621 (2009).
10. van Baarsen, L. G., Bos, C. L., van der Pouw Kraan, T. C. & Verweij, C. L. Transcription profiling of rheumatic diseases. Arthritis Res. Ther. 11, 207 (2009).